CSL (CMXHF) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 31 192 sessions, October 31, 2025 to November 2, 2026
- Largest daily move
- +13.5% close of August 18, 2026
- 1-year change
- +14.5% closing prices, October 31, 2025 to November 2, 2026
- 1-month change
- +9.1% closing prices, September 30, 2026 to November 2, 2026
Company Description
CSL (OTC: CMXHF) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $66.8B.
CMXHF has gained 14.5% over the past year. The last closing price was $139.16.
This page collects what Stock Titan holds for CMXHF, including price data, SEC filings, and short interest trends.
Stock Performance
CSL (CMXHF) closed at $139.16 on November 2, 2026. Over the past 12 months, the price has gained 14.5%.
CMXHF Metrics & Rankings
Price returns through November 2, 2026. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
SEC Filings
CSL has filed 2 recent SEC filings, including 1 Form EFFECT, 1 Form F-6. The most recent filing was submitted on . SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all CMXHF SEC filings →
Short Interest History
Short interest in CSL (CMXHF) currently stands at 675.2 thousand shares, down 1.4% from the previous reporting period, representing 0.1% of the float. Since November 2025, short interest has increased by 38.4%.
Days to Cover History
Days to cover for CSL (CMXHF) currently stands at 1000.0 days. The ratio is the reported short interest divided by the average daily trading volume. Since November 2025, the figure has increased by 212.5%. Across the settlements charted above, it has ranged from 25.4 to 1000.0 days.
CMXHF Company Profile & Sector Positioning
CSL (CMXHF) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing CMXHF often look at related companies in the same sector, including UCB SA NPV (UCBJF), UCB SA (UCBJY), Genmab A/S DKK (GNMSF), WuXi Biologics (WXXWY), and Innovent Biolgcs (IVBIY). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CMXHF's relative position within its industry.